|
||||||||||||||
Dave Wright (School of Computing and Mathematics)Professor Dave Wright (School of Computing and Mathematics)
Dave Wright (School of Computing and Mathematics) has not published any more information
Books
Peace KE (ed.)
(2009)
Design and Analysis of Clinical Trials with Time-to-Event Endpoints.
Chapman & Hall/CRC
Chapters
(2002)
'Scoring tests when items have been generated'
in Irvine S,Kyllonen PC (ed.)
Item Generation
Lawrence Erlbaum Associates
p 376
Conference Papers
(2009)
'THE EPIDEMIOLOGY OF MOTOR NEURONE DISEASE IN TWO COUNTIES IN THE SOUTH WEST OF ENGLAND'
ABN Joint Annual Meeting/Spanish-Society-of-Neurology.
Liverpool, ENGLAND
22/06/2009
- 26/06/2009
B M J PUBLISHING GROUP
, DOI: 10.1136/jnnp.2009.191759a
(2006)
'Repeated measures screening for trisomy 21 - Results from a general population screening trial (the faster trial)'
27th Annual Meeting of the Society-of-Maternal-Fetal-Medicine.
San Francisco, CA
05/02/2007
- 10/02/2007
MOSBY-ELSEVIER
pp S13 - S13
, DOI: 10.1016/j.ajog.2006.10.032
(2006)
'CAMS revisited: An efficient Bayesian analysis of Ashworth and Rivermead data'
Clinical Neurosciences 2005 Meeting.
Torquay, ENGLAND
07/09/2005
- 09/09/2005
B M J PUBLISHING GROUP
pp 132 - 132
(2006)
'Correlations between cannabinoid levels and the Ashworth Score Support results from the CAM trial'
Clinical Neurosciences 2005 Meeting.
Torquay, ENGLAND
07/09/2005
- 09/09/2005
B M J PUBLISHING GROUP
pp 139 - 139
(2006)
'Does the GHQ-30 leave room for change?'
Clinical Neurosciences 2005 Meeting.
Torquay, ENGLAND
07/09/2005
- 09/09/2005
B M J PUBLISHING GROUP
pp 134 - 134
(2006)
'Introducing the south west impact of multiple sclerosis (SWIMS) project: A population-based natural history project to acquire patient-orientated information about the impact of multiple sclerosis'
Clinical Neurosciences 2005 Meeting.
Torquay, ENGLAND
07/09/2005
- 09/09/2005
B M J PUBLISHING GROUP
pp 131 - 131
(2006)
'Meaningless statistics and the illusion of fatigue'
Clinical Neurosciences 2005 Meeting.
Torquay, ENGLAND
07/09/2005
- 09/09/2005
B M J PUBLISHING GROUP
pp 133 - 133
(2005)
'Confounding the confused: Is measuring the frequency and severity of cognitive impairment really necessary?'
18th World Congress of Neurology.
Sydney, AUSTRALIA
05/11/2005
- 11/11/2005
ELSEVIER SCIENCE BV
pp S220 - S220
(2005)
'Confounding the confused: is measuring the frequency and severity of cognitive impairment really necessary?'
21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS.
Thessaloniki, GREECE
28/09/2005
- 01/10/2005
HODDER ARNOLD, HODDER HEADLINE PLC
pp S68 - S68
(2005)
'Introducing the South West Impact of Multiple Sclerosis Project: a patient-focused natural history study of multiple sclerosis'
21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS.
Thessaloniki, GREECE
28/09/2005
- 01/10/2005
HODDER ARNOLD, HODDER HEADLINE PLC
pp S110 - S110
(2005)
'Meaningless statistics and the illusion of fatigue measurement'
21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS.
Thessaloniki, GREECE
28/09/2005
- 01/10/2005
HODDER ARNOLD, HODDER HEADLINE PLC
pp S68 - S68
(2005)
'The relationship between cannabinoid levels and clinical effect in multiple sclerosis'
21st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis/10th Annual Meeting of Rehabilitation in MS.
Thessaloniki, GREECE
28/09/2005
- 01/10/2005
HODDER ARNOLD, HODDER HEADLINE PLC
pp S90 - S90
(2005)
'Do blood levels explain clinical differences between whole extract of cannabis and pure delta-9-tetrahydrocannabinol in the treatment of multiple sclerosis symptoms?'
15th Meeting of the European-Neurological-Society.
Vienna, AUSTRIA
18/06/2005
- 22/06/2005
DR DIETRICH STEINKOPFF VERLAG
pp 110 - 110
(2004)
'Cannabinoids in multiple sclerosis (CAMS) study, follow-up data suggesting an effect on disease progression'
14th Meeting of the European-Neurological-Society.
Barcelona, SPAIN
26/06/2004
- 30/06/2004
DR DIETRICH STEINKOPFF VERLAG
pp 44 - 44
(2004)
'Cannabinoids in MS - Long-term results from the CAMS'
Spring Meeting of the Association-of-British-Neurologists.
London, ENGLAND
14/04/2004
- 16/04/2004
B M J PUBLISHING GROUP
pp 1215 - 1215
(1994)
'ESTIMATING THE UNCERTAINTY IN REPORTED DOWN-SYNDROME DETECTION RATES - APPLICATION OF MATHEMATICAL-MODELING TECHNIQUES TO THE TRIPLE TEST AND FREE BETA-INTACT HCG'
in Farriaux JP,Dhondt JL (ed.)
9th International Neonatal Screening Symposium/2nd Meeting of the International-Society-for-Neonatal-Screening.
LILLE, FRANCE
13/09/1993
- 17/09/1993
ELSEVIER SCIENCE PUBL B V
pp 353 - 356
Other Publications
Birth Statistics.
London:
Journals
Articles
(2012)
'Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review.'
Int Psychogeriatr
24
(5),
pp 689 - 697
, DOI: 10.1017/S1041610211001116
(2011)
'A reassessment of biochemical marker distributions in trisomy 21-affected and unaffected twin pregnancies in the first trimester'
ULTRASOUND OBST GYN
37
(1),
pp 38 - 47
, DOI: 10.1002/uog.8845
(2011)
'Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011'
PRENATAL DIAG
31
(6),
pp 519 - 522
, DOI: 10.1002/pd.2730
(2011)
'BECKMAN COULTER TOTAL HUMAN CHORIONIC GONADOTROPHIN (HCG) AND INHIBIN A IN SECOND TRIMESTER DOWN'S SCREENING USING A QUADRUPLE TEST: A RETROSPECTIVE COMPARISON WITH TRIPLE TESTING'
CLIN CHEM LAB MED
49,
pp S709 - S709
(2011)
'First-Trimester Screening for Trisomy 21 Using Alpha-Fetoprotein'
FETAL DIAGN THER
30
(3),
pp 215 - 218
, DOI: 10.1159/000330198
(2011)
'First-trimester screening for trisomy 21 with adjustment for biochemical results of previous pregnancies.'
Fetal Diagn Ther
30
(3),
pp 194 - 202
, DOI: 10.1159/000328710
(2011)
'Impact of bias in serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A multiples of the median levels on first-trimester screening for trisomy 21.'
Ultrasound Obstet Gynecol
38
(3),
pp 309 - 313
, DOI: 10.1002/uog.8987
(2011)
'Prediction of Small-for-Gestation Neonates from Biophysical and Biochemical Markers at 11-13 Weeks'
FETAL DIAGN THER
29
(2),
pp 148 - 154
, DOI: 10.1159/000321694
(2011)
'Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model.'
Prenat Diagn
31
(1),
pp 16 - 21
, DOI: 10.1002/pd.2643
(2011)
'The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D.'
Mult Scler
,
, DOI: 10.1177/1352458511429319
(2010)
'Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.'
Health Technol Assess
14
(33),
pp 1 - 80
, DOI: 10.3310/hta14330
(2010)
'First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker'
REPROD BIOL ENDOCRIN
8,
, DOI: 10.1186/1477-7827-8-129
(2010)
'First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation.'
Ultrasound Obstet Gynecol
36
(4),
pp 404 - 411
, DOI: 10.1002/uog.7755
(2010)
'First-trimester combined screening for trisomy 21 at 8-13 weeks'
,
(2010)
'Intra- and interoperator reliability of manual and semi-automated measurement of fetal nuchal translucency by sonographers with different levels of experience'
ULTRASOUND OBST GYN
36
(4),
pp 417 - 422
, DOI: 10.1002/uog.8809
(2010)
'Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort.'
BMC Neurol
10,
p 88
, DOI: 10.1186/1471-2377-10-88
(2010)
'Semi-automated system for measurement of nuchal translucency thickness'
ULTRASOUND OBST GYN
36
(4),
pp 412 - 416
, DOI: 10.1002/uog.7737
(2010)
'The epidemiology of motor neurone disease in two counties in the southwest of England'
Journal of Neurology
,
http://www.springerlink.com/content/88j72u68857nrp57/
(2010)
'The epidemiology of motor neurone disease in two counties in the southwest of England'
257
(6),
pp 977 - 981
(2010)
'Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing'
ULTRASOUND OBST GYN
36
(5),
pp 542 - 547
, DOI: 10.1002/uog.7663
(2010)
'Validation of the patient activation measure in a multiple sclerosis clinic sample and implications for care.'
Disabil Rehabil
32
(19),
pp 1558 - 1567
, DOI: 10.3109/09638280903567885
(2009)
'Calculating patient-specific risk for Down Syndrome: does software matter?'
33
(2),
pp 133 - 134
http://www.ncbi.nlm.nih.gov/pubmed/19173232?ordinalpos=11&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum
(2009)
'Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation'
ULTRASOUND OBST GYN
33
(5),
pp 512 - 517
, DOI: 10.1002/uog.6330
(2009)
'Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21'
33
(6),
pp 657 - 664
http://dx.doi.org/10.1002/uog.6370
(2009)
'Effect of Deviation of Nuchal Translucency Measurements on the Performance of Screening for Trisomy 21 EDITORIAL COMMENT'
OBSTET GYNECOL SURV
64
(10),
pp 648 - 649
(2009)
'Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation'
ULTRASOUND OBST GYN
33
(3),
pp 259 - 264
, DOI: 10.1002/uog.6318
(2009)
'Prospective validation of first-trimester combined screening for trisomy 21'
ULTRASOUND OBST GYN
34
(1),
pp 14 - 18
, DOI: 10.1002/uog.6412
(2009)
'Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation'
33
(1),
pp 18 - 22
http://cat.inist.fr/?aModele=afficheN&cpsidt=20993751
(2008)
'A mixture model of nuchal translucency thickness in screening for chromosomal defects'
31
(4),
pp 376 - 383
http://www.ingentaconnect.com/content/jws/uog/2008/00000031/00000004/art00003%20http://dx.doi.org/10.1002/uog.5299
(2008)
'Contingent screening for Down syndrome - results from the FaSTER trial'
28,
pp 89 - 94
(2008)
'Contingent screening for Down syndrome - results from the FaSTER trial'
28
(2),
pp 89 - 94
http://dx.doi.org/10.1002/pd.1913
, DOI: 10.1002/pd.1913
(2008)
'First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics'
31
(5),
pp 493 - 502
http://dx.doi.org/10.1002/uog.5332
(2008)
'Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free b-hCG and pregnancy-associated plasma protein-A'
23
(9),
pp 1968 - 1975
(2008)
'Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free β-hCG and pregnancy-associated plasma protein-A'
23
(9),
pp 1968 - 1975
http://humrep.oxfordjournals.org/cgi/content/abstract/den224v1
(2008)
'Screening for trisomy 18 by maternal age, fetal nuchal translucency, free ß-hCG human chorionic gonadotropin and pregnancy-associated plasma protein-A'
32
(4),
pp 488 - 492
http://www.ingentaconnect.com/content/jws/uog/2008/00000032/00000004/art00004%20http://dx.doi.org/10.1002/uog.6123
(2008)
'Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A'
ULTRASOUND OBST GYN
31
(6),
pp 618 - 624
, DOI: 10.1002/uog.5331
(2008)
'Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.'
31
(6),
pp 618 - 624
http://www.ncbi.nlm.nih.gov/pubmed/18461550
(2008)
'Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free-beta human chorionic gonadotropin and pregnancy-associated plasma protein-A'
31,
pp 618 - 624
(2008)
'The 1(st) trimester screening of Trisomie 21, 18 and 13 of maternal age, fetal NT and heart frequency, free beta HCC & PAPP-A'
GEBURTSH FRAUENHEILK
68,
pp S8 - S8
(2007)
'First trimester screening for Down syndrome using free beta hCG, total hCG and PAPP-A: an exploratory study'
Prenatal Diagnosis
27
(12),
pp 1118 - 1122
(2007)
'Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis'
Health Technology Assessment
11
(34),
pp 1 - +
(2007)
'The impact of bias in MoM values on patient risk and screening performance for Down syndrome'
Prenatal Diagnosis
27
(9),
pp 840 - 845
(2007)
'The impact of maternal glycemia and obesity on early postnatal growth in a nondiabletic Caucasian population'
DIABETES CARE
30
(4),
pp 777 - 783
, DOI: 10.2337/dc06-1849
(2007)
'The impact of maternal glycemia and obesity on early postnatal growth in a nondiabletic Caucasian population'
Diabetes Care
30
(4),
pp 777 - 783
(2006)
'16-detector row computed tomographic coronary angiography in patients undergoing evaluation for aortic valve replacement: comparison with catheter angiography'
Clinical Radiology
61
(9),
pp 749 - 757
(2006)
'A matter of opinion or evidence!'
Prenatal Diagnosis
26
(12),
pp 1184 - 1184
(2006)
'Assessing newborn body composition using principal components analysis: differences in the determinants of fat and skeletal size'
6
(24),
http://www.biomedcentral.com/1471-2431/6/24
(2006)
'Assessing newborn body composition using principal components analysis: differences in the determinants of fat and skeletal size.'
BMC Pediatr
6,
p 24
, DOI: 10.1186/1471-2431-6-24
(2006)
'CAMS revisited: An efficient Bayesian analysis of Ashworth and Rivermead data'
Journal of Neurology Neurosurgery and Psychiatry
77
(1),
p 34
(2006)
'Correlations between cannabinoid levels and the Ashworth Score Support results from the CAM trial'
Journal of Neurology Neurosurgery and Psychiatry
77
(1),
p 73
(2006)
'CT ratios: Parameter estimates are inconsistent with SURUSS publications?'
Prenatal Diagnosis
26
(10),
pp 991 - 992
(2006)
'Does the GHQ-30 leave room for change?'
Journal of Neurology Neurosurgery and Psychiatry
77
(1),
p 43
(2006)
'Introducing the south west impact of multiple sclerosis (SWIMS) project: A population-based natural history project to acquire patient-orientated information about the impact of multiple sclerosis'
Journal of Neurology Neurosurgery and Psychiatry
77
(1),
p 31
(2006)
'Maternal glucose levels influence birthweight and 'catch-up' and 'catch-down' growth in a large contemporary cohort'
Diabetic Medicine
23
(11),
pp 1207 - 1212
(2006)
'Maternal glucose levels influence birthweight and 'catch-up' and 'catch-down' growth in a large contemporary cohort'
DIABETIC MED
23
(11),
pp 1207 - 1212
, DOI: 10.1111/j.1464-5491.2006.01964.x
(2006)
'Meaningless statistics and the illusion of fatigue'
Journal of Neurology Neurosurgery and Psychiatry
77
(1),
p 39
(2006)
'Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: A validation study'
Prenatal Diagnosis
26
(8),
pp 730 - 739
(2006)
'Repeated measures screening for trisomy 21 - Results from a general population screening trial (the faster trial)'
American Journal of Obstetrics and Gynecology
195
(6),
p 27
(2006)
'Reproducibility of Risk Figures in 2nd-Trimester Maternal Serum Screening for Down Syndrome: Comparison of 2 Laboratories'
52
(11),
pp 2087 - 2094
http://www.clinchem.org/cgi/content/full/52/11/2087?SEARCHID=1&hits=10&VOLUME=52&ISSUE=11&gca=clinchem%3B52%2F11%2F2087&FIRSTINDEX=0&FULLTEXT=Down+Syndrome&
(2006)
'The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS)'
INT UROGYNECOL J
17
(6),
pp 636 - 641
, DOI: 10.1007/s00192-006-0086-x
(2006)
'The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS)'
International Urogynecology Journal
17
(6),
pp 636 - 641
(2006)
'Three-stage contingent screening for Down syndrome'
Prenatal Diagnosis
26
(6),
pp 528 - 534
(2005)
'Cannabinoids in multiple sclerosis (CAM) study: safety and efficacy data for 12-month follow-up'
Journal of Neurology Neurosurgery & Psychiatry
76
(12),
pp 1664 - 1669
, DOI: 10.1136/jnnp.2005.070136
(2005)
'Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up'
Journal of Neurology Neurosurgery and Psychiatry
76
(12),
pp 1664 - 1669
(2005)
'Confounding the confused: is measuring the frequency and severity of cognitive impairment really necessary?'
Multiple Sclerosis
11,
pp S68 - S68
(2005)
'Confounding the confused: Is measuring the frequency and severity of cognitive impairment really necessary?'
Journal of the Neurological Sciences
238,
pp S220 - S220
(2005)
'Do blood levels explain clinical differences between whole extract of cannabis and pure delta-9-tetrahydrocannabinol in the treatment of multiple sclerosis symptoms?'
Journal of Neurology
252,
pp 110 - 110
(2005)
'Down syndrome screening in the first and/or second trimester: Model predicted performance using meta-analysis parameters'
Seminars in Perinatology
29
(4),
pp 252 - 257
(2005)
'Economic modelling of antenatal screening and ultrasound scanning programmes for identification of fetal abnormalities'
Bjog-An International Journal of Obstetrics and Gynaecology
112
(7),
pp 866 - 874
(2005)
'Introducing the South West Impact of Multiple Sclerosis Project: a patient-focused natural history study of multiple sclerosis'
Multiple Sclerosis
11,
pp S110 - S110
(2005)
'Maternal BMI not maternal glucose alters early childhood growth'
Pediatric Research
58
(5),
pp 1105 - 1105
(2005)
'Meaningless statistics and the illusion of fatigue measurement'
Multiple Sclerosis
11,
pp S68 - S68
(2005)
'Practical strategies in contingent sequential screening for Down syndrome'
Prenatal Diagnosis
25
(8),
pp 645 - 652
(2005)
'Practical strategies in contingent sequential screening for Down syndrome'
25
(8),
pp 645 - 652
http://dx.doi.org/10.1002/pd.1215
(2005)
'Repeated measures screening for Down's syndrome'
British Journal of Obstetrics and Gynaecology
112 (1),
pp 80 - 83
, DOI: 10.1111/j.1471-0528.2004.00343.x
(2005)
'The relationship between cannabinoid levels and clinical effect in multiple sclerosis'
Multiple Sclerosis
11,
pp S90 - S90
(2005)
'Which contingent sequential screening protocol?'
Prenatal Diagnosis
25
(6),
pp 520 - 521
(2005)
'Which contingent sequential screening protocol?: A response'
Prenatal Diagnosis
25
(12),
pp 1169 - 1170
(2004)
'Cannabinoids in MS - Long-term results from the CAMS'
Journal of Neurology Neurosurgery and Psychiatry
75
(8),
p 11
(2004)
'Cannabinoids in multiple sclerosis (CAMS) study, follow-up data suggesting an effect on disease progression'
Journal of Neurology
251,
pp 44 - 44
(2004)
'Cannabis for dyskinesia in Parkinson disease - A randomized double-blind crossover study'
Neurology
63
(7),
pp 1245 - 1250
(2004)
'Cannabis for Dyskinesia in Parkinson Disease: a Randomised Double-blind Crossover Study'
Neurology
63,
pp 1245 - 1250
(2004)
'Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening'
Prenatal Diagnosis
24
(10),
pp 762 - 766
(2004)
'Cost utility of prenatal diagnosis'
Lancet
363
(9415),
pp 1164 - 1165
(2004)
'Epidural infusion or combined femoral and sciatic nerve blocks as perioperative analgesia for knee arthroplasty'
British Journal of Anaesthesia
93
(3),
pp 368 - 374
(2004)
'The accuracy of birth weight'
J CLIN NURS
13
(6),
pp 767 - 768
(2004)
'The accuracy of birth weight'
Journal of Clinical Nursing
13
(6),
pp 767 - 768
(2004)
'Weight differences in Plymouth toddlers compared to the British Growth Reference Population'
ARCH DIS CHILD
89
(9),
pp 843 - 844
, DOI: 10.1136/adc.2003.041061
(2004)
'Weight differences in Plymouth toddlers compared to the British Growth Reference Population'
Archives of Disease in Childhood
89
(9),
pp 843 - 844
(2004)
'Weight Differences in Plymouth Toddlers Compared to the British Growth Reference Population'
Archives of Diseases in Childhood
89
(9),
pp 843 - 844
(2003)
'A mixture model for rounded data'
Journal of the Royal Statistical Society Series D-the Statistician
52,
pp 3 - 13
(2003)
'Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial'
Lancet
362
(9395),
pp 1517 - 1526
(2003)
'Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial '
The Lancet
362
(9395),
pp 1517 - 1526
, DOI: 10.1016/S0140-6736(03)14738-1
(2003)
'Changes in resuscitation practice at birth'
Archives of Disease in Childhood
88
(5),
pp F375 - F379
(2003)
'EDD how well do midwives do?'
Midwifery
19,
pp 125 - 131
(2003)
'First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population'
22,
pp 149 - 151
(2003)
'How well do midwives estimate the date of delivery?'
Midwifery
19
(2),
pp 125 - 131
(2003)
'How well do midwives estimate the date of delivery?'
MIDWIFERY
19
(2),
pp 125 - 131
, DOI: 10.1054/midw.2002.0344
(2003)
'Intubation at birth - What's the need?'
Pediatric Research
53
(4),
p 2629
(2002)
'Prolene hernia system compared with lichtenstein patch: A randomised double blind study of short term and medium term outcomes in inguinal hernia repair'
Hernia
6,
pp 113 - 119
(2001)
'Drinking water composition and childhood-onset Type 1 diabetes mellitus in Devon and Cornwall, England'
Diabetic Medicine
18
(9),
pp 709 - 717
(2001)
'Drinking water composition and childhood-onset Type 1 diabetes mellitus in Devon and Cornwall, England.'
Diabet Med
18
(9),
pp 709 - 717
(2001)
'Randomised study comparing extent of hypocarbia in preterm infants during conventional and patient triggered ventilation'
Archives of Disease in Childhood
84
(1),
pp F14 - F17
(2000)
'Estimating birth prevalence of Down's syndrome.'
J Epidemiol Biostat
5
(2),
pp 89 - 97
(1998)
'Application of Markov chain Monte Carlo methods to modelling birth prevalence of Down syndrome'
J ROY STAT SOC C-APP
47,
pp 589 - 602
(1998)
'Estimating the spontaneous loss of Down syndrome fetuses between the times of chorionic villus sampling, amniocentesis and livebirth.'
Prenat Diagn
18
(10),
pp 1045 - 1054
(1998)
'Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets.'
Prenat Diagn
18
(1),
pp 9 - 20
(1998)
'On shape detection in noisy images with particular reference to ultrasonography'
STAT COMPUT
8
(4),
pp 377 - 389
(1997)
'Illness severity measured by CRIB score: a product of changes in perinatal care?'
Arch Dis Child Fetal Neonatal Ed
77
(3),
pp F211 - F215
(1997)
'Nonparametric density estimation and discrimination from images of shapes'
APPL STAT-J ROY ST C
46
(3),
pp 365 - 380
(1996)
'A new approach to exploring biases in educational assessment.'
Br J Psychol
87 ( Pt 4),
pp 515 - 534
(1996)
'S-Plus version 3.2, release 1 for Windows'
BRIT J MATH STAT PSY
49,
pp 206 - 208
(1993)
'Assessment of atypicality: an adjunct to prenatal screening for Down's syndrome that facilitates detection of other abnormalities.'
Ann Clin Biochem
30 ( Pt 6),
pp 578 - 583
(1993)
'Quality of life measurement.'
Monaldi Arch Chest Dis
48
(5),
pp 549 - 553
(1988)
'Investigation and comparison of some models for removing ocular artefacts from EEG signals. Part 1. Review of models and data analysis.'
Med Biol Eng Comput
26
(6),
pp 584 - 590
(1988)
'Investigation and comparison of some models for removing ocular artefacts from EEG signals. Part 2. Quantitative and pictorial comparison of models.'
Med Biol Eng Comput
26
(6),
pp 591 - 598
Letters
(2008)
'Contingent screening for Down syndrome'
PRENATAL DIAG
28
(8),
pp 782 - 782
, DOI: 10.1002/pd.2044
(1998)
'Response to: Wald, N.J., Hackshaw, A.K. (1997). Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome, Prenat. Diagn., 17, 821-829.'
PRENATAL DIAG
18
(5),
pp 511 - 515
|
||||||||||||||